Developing uses for sugar-cane bagasse: Biotechnology applied to the paper industry

Sugar-cane bagasse is a fibrous waste-product of the sugar refining industry, which can be recycled as a raw material for paper manufacture. IRD researchers have elaborated a new bioprocess that transforms the bagasse into paper pulp and also produces an industrially useful enzyme, laccase. The process is based on the metabolism of a filamentous fungus. Preliminary laboratory trials show that this integrated bioprocess can be adapted to other potential fibre-yielding materials, opening up promising applications for the paper industry.

Diabetes :: Stem Cells can cure diabetes

Researchers from the New Orleans’ Tulane University reveal that stem cells can cure diabetes. Researchers have used stem cells from human bone marrow to successfully treat diabetic mice.

Health :: Abbott to Expand Presence in Lipid Management Market with Acquisition of Kos Pharmaceuticals

Abbott and Kos Pharmaceuticals, Inc. today announced a definitive agreement for Abbott to acquire Kos for $78 per share in cash, for a total transaction value of $3.7 billion, net of cash currently held by Kos. Based in Cranbury, N.J., Kos is a specialty pharmaceutical company that develops and markets proprietary medications for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company has a growing presence in the $20 billion lipid management market.

Health :: Cooking and eating tips for weight loss during holidays

It is possible to enjoy the tempting offerings of the holiday season and still manage your weight, according to nutrition and weight management expert Madelyn Fernstrom, Ph.D., director of the UPMC (University of Pittsburgh Medical Center) Weight Management Center.

Diabetes :: Accurate coding is key to preventing potentially serious health complications associated with insulin overdose

Significant errors in insulin dose can result when blood glucose meters are miscoded according to new clinical study. When persons with diabetes use miscoded blood glucose meters to determine how much insulin to take, significant errors in insulin dose can result that may potentially lead to short- and long-term health complications, according to findings of a new study presented at the Sixth Annual Diabetes Technology Meeting in Atlanta, Georgia.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack